Darrick Carter

Darrick Carter is an American biochemist/biophysicist, inventor, and entrepreneur. He is known for developing various therapeutics and vaccines, such as saRNA COVID-19 vaccine, influenza vaccine, and tuberculosis vaccine. Currently, he is the CEO of Compliment Corporation, and PAI Life Sciences Incorporated, as well as Founder of HDT Bio Corporation. He also holds two affiliate Professorships at the University of Washington in the Schools of Medicine and in Global Health.

Carter has published over 100 papers, and is the inventor over 180 patents and applications. He focuses his research work on the molecule drug and biologics production, development and commercial deployment. He is the scientific advisor for several vaccine and global health institutes, and serves on the board of DendriBio. Provided by Wikipedia
Showing 1 - 6 results of 6 for search 'Darrick Carter', query time: 0.02s Refine Results
  1. 1
    CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells

    CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cel... by Hongjie Wang, Theo Koob, Jonathan R. Fromm, Ajay Gopal, Darrick Carter, André Lieber

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses

    Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses by Anthony L. Desbien, Neal Van Hoeven, Steven J. Reed, Allen C. Casey, John D. Laurance, Susan L. Baldwin, Malcolm S. Duthie, Steven G. Reed, Darrick Carter

    Published 2013-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen.

    Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen. by Paul F McKay, Alethea V Cope, Jamie F S Mann, Sarah Joseph, Mariano Esteban, Roger Tatoud, Roger Tatoud, Darrick Carter, Steven G Reed, Jonathan Weber, Robin J Shattock

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant.

    Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant. by Rhea N Coler, Sylvie Bertholet, Magdalini Moutaftsi, Jeff A Guderian, Hillarie Plessner Windish, Susan L Baldwin, Elsa M Laughlin, Malcolm S Duthie, Christopher B Fox, Darrick Carter, Martin Friede, Thomas S Vedvick, Steven G Reed

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Potential biomarker and composite efficacy readout for human clinical trials of schistosomiasis vaccine in Africa

    Potential biomarker and composite efficacy readout for human clinical trials of schistosomiasis vaccine in Africa by Desalegn W. Kifle, Aravindan Kalyanasundaram, Adebayo J. Molehin, Mumtaz Y. Balkhi, Aryandra Arya, Weidong Zhang, Gul Ahmad, Workineh Torben, David Carey, James F. Papin, Lisa A. Jackson, Sean A. Gray, Darrick Carter, Afzal A. Siddiqui

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.

    Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study. by Catherine A Cosgrove, Charles J Lacey, Alethea V Cope, Angela Bartolf, Georgina Morris, Celine Yan, Susan Baden, Tom Cole, Darrick Carter, Elizabeth Brodnicki, Xiaoying Shen, Sarah Joseph, Stephen C DeRosa, Lili Peng, Xuesong Yu, Guido Ferrari, Mike Seaman, David C Montefiori, Nicole Frahm, Georgia D Tomaras, Wolfgang Stöhr, Sheena McCormack, Robin J Shattock

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: